Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

Ironwood Pharmaceuticals Inc

IRWD
5,83
-0,15 (-2,51%)
15 Giu 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
12/6/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/6/202422:57EDGAR2Form 144 - Report of proposed sale of securities
07/6/202419:35EDGAR2Form 144 - Report of proposed sale of securities
06/6/202421:57EDGAR2Form 144 - Report of proposed sale of securities
30/5/202422:01BWIronwood Pharmaceuticals to Participate in the Jefferies..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202412:00BWIronwood Late-Breaker Oral Presentation at Digestive Disease..
20/5/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/5/202422:11EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:08EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:07EDGAR2Form 144 - Report of proposed sale of securities
17/5/202422:04EDGAR2Form 144 - Report of proposed sale of securities
09/5/202422:46EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202413:09EDGAR2Form 8-K - Current report
09/5/202413:00BWIronwood Pharmaceuticals Reports First Quarter 2024 Results
06/5/202422:01BWIronwood Pharmaceuticals to Participate in The Citizens JMP..
01/5/202413:30BWIronwood Pharmaceuticals to Present New Data on Once-Weekly..
25/4/202422:01BWIronwood Pharmaceuticals to Host First Quarter 2024 Investor..
28/3/202412:30BWIronwood Pharmaceuticals Announces Positive Results from its..
08/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202412:00BWIronwood Pharmaceuticals Announces Positive Topline Results..
23/2/202413:30BWIronwood Pharmaceuticals to Present Four Abstracts at the..
15/2/202413:04EDGAR2Form 8-K - Current report
15/2/202413:00BWIronwood Pharmaceuticals Reports Fourth Quarter and Full..
15/2/202403:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202402:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202422:13EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:11EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:09EDGAR2Form 144 - Report of proposed sale of securities
09/2/202422:05EDGAR2Form 144 - Report of proposed sale of securities
01/2/202422:01BWIronwood Pharmaceuticals to Host Fourth Quarter and Full..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202401:00BWIronwood Announces Publication in The Lancet..
08/1/202412:05EDGAR2Form 8-K - Current report
08/1/202412:00BWIronwood Pharmaceuticals Maintains FY 2023 Financial..
03/1/202422:01BWIronwood Pharmaceuticals to Present at the 42nd Annual J.P...
Apertura: 5,94 Min: 5,69 Max: 5,94
Chiusura: 5,98

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network